patients with ulcerative colitis in remission were randomly allocated to treatment with sulphasalazine ( 2 g/day ) or oral sodium cromoglycate ( 160 mg/day or 2 g/day ) , and the relapse rates in these treatment groups were compared during continued treatment for one year .
C0009324
ulcerative colitis
C0036078
sulphasalazine